Perella Weinberg Partners Capital Management’s Pfizer PFE Stock Holding History

Perella Weinberg Partners Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-25,732	Closed	-$723K	–	62
2016 Q1	$723K	Buy	+25,732	New	+$735K	0.31%	38
2015 Q4	–	Sell	-12,648	Closed	-$377K	–	64
2015 Q3	$377K	Buy	+12,648	New	+$406K	0.16%	42
2015 Q2	–	Sell	-31,620	Closed	-$1.04M	–	74
2015 Q1	$1.04M	Sell	31,620 -63,240	-67%	-$2.01M	0.99%	32
2014 Q4	$2.8M	Buy	+94,860	New	+$2.72M	0.54%	57
2014 Q3	–	Sell	-59,730	Closed	-$1.68M	–	158
2014 Q2	$1.68M	Sell	59,730 -145,210	-71%	-$4.14M	0.13%	110
2014 Q1	$6.25M	Buy	+204,940	New	+$6.11M	0.82%	35
2013 Q4	–	Sell	-179,180	Closed	-$4.88M	–	118
2013 Q3	$4.88M	Sell	179,180 -60,555	-25%	-$1.65M	0.52%	55
2013 Q2	$6.37M	Buy	+239,735	New	+$6.62M	0.43%	80

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Perella Weinberg Partners Capital Management's PFE Position: Q2 2016 in Review

Perella Weinberg Partners Capital Management sold out of Pfizer (PFE) in Q2 2016, closing a stake of 25,732 shares — an estimated $723K sold.

Perella Weinberg Partners Capital Management first reported a position in PFE in Q2 2013 and held it in 8 quarters. The position peaked at $6.37M in Q2 2013. 1,991 funds tracked by Wall St. Rank hold PFE as of Q2 2016.

Perella Weinberg Partners Capital Management reported no remaining Pfizer position as of Q2 2016 after selling out during the quarter.
Perella Weinberg Partners Capital Management sold 25,732 Pfizer shares in Q2 2016, an estimated $723K.
Perella Weinberg Partners Capital Management first reported a position in Pfizer in Q2 2013 and held it in 8 quarters.
Perella Weinberg Partners Capital Management's Pfizer position peaked at $6.37M in Q2 2013.
1,991 funds tracked by Wall St. Rank held Pfizer as of Q2 2016.

Based on Perella Weinberg Partners Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.